Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Rockville, MD
SEC filing record 1 source field available
Fiscal year end
31 December
SUPERNUS PHARMACEUTICALS, INC. has filed 1,156 SEC EDGAR filings since 06 Mar 2006

SEC filing history

Showing 101-125 of 1,000 matching filings.

Per page
25
Current page
5
4

FORM 4

Filing date
09 Sep 2025
Reporting date
08 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Sep 2025
Reporting date
05 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-35518

144 filing

Filing date
08 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-35518

144 filing

Filing date
05 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
29 Aug 2025
Reporting date
27 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
29 Aug 2025
Reporting date
27 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-35518

144 filing

Filing date
28 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Aug 2025
Reporting date
25 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Aug 2025
Reporting date
25 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Aug 2025
Reporting date
25 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Aug 2025
Reporting date
25 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-35518

144 filing

Filing date
27 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
26 Aug 2025
Reporting date
22 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
26 Aug 2025
Reporting date
22 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
26 Aug 2025
Reporting date
22 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-35518

144 filing

Filing date
25 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-35518

144 filing

Filing date
25 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-35518

144 filing

Filing date
25 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-35518

144 filing

Filing date
22 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-35518

144 filing

Filing date
22 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-35518

144 filing

Filing date
22 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 Aug 2025
Reporting date
14 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 Aug 2025
Reporting date
14 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-86843

SCHEDULE 13G/A filing

Filing date
15 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-35518

144 filing

Filing date
14 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .